SCHEMBL4855044

SCHEMBL4855044

Cc1ccccc1-c1ccc(OCCN(C)C)c(C(=O)C=Cc2ccccc2CN(C)CCN(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 9/20 0.46
HRH1 P35367 2/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ESR1 P03372 1/20 0.36
BCHE P06276 2/20 0.36
ACHE P22303 2/20 0.36
MCHR1 Q99705 1/20 0.35
PTPN11 Q06124 1/20 0.35
AR P10275 1/20 0.35
HTR7 P34969 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854689 1.00 SLC6A9 (0.46) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4853568 0.94 SLC6A9 (0.46) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4847435 0.94 SLC6A9 (0.46) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4854695 0.90 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4854860 0.90 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4853574 0.90 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4856457 0.89 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1BCHE
SCHEMBL4854469 0.89 SLC6A9 (0.43) SLC6A9HRH1KDM4EALDH1A1BCHE
SCHEMBL4850218 0.87 SLC6A9 (0.44) SLC6A9KDM4EALDH1A1SMN1; SMN2BCHE
SCHEMBL4849684 0.87 SLC6A9 (0.44) SLC6A9KDM4EALDH1A1SMN1; SMN2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed